First human test for new Triple-Threat booster shot
NCT ID NCT07492303
Summary
This is an early-stage study to check the safety and immune response of a new combined vaccine for adolescents and adults. The vaccine aims to protect against whooping cough (pertussis), diphtheria, and tetanus. Researchers will give different doses to 96 healthy volunteers aged 10 and older to see how well it is tolerated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.